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Introduction
Endoscopic submucosal dissection (ESD) has been widely ac-
cepted as a minimally invasive alternative treatment for super-
ficial esophageal neoplasia without obvious lymph node or dis-
tant metastases because it allows successful en bloc removal,
even for superficially spreading esophageal carcinoma [1]. Re-
cently, some studies have shown that long-term ESD outcomes
are good and are comparable to those of radical esophagect-
omy [2, 3].
Despite its high curability, stricture formation after exten-
sive resection remains an issue. Stricture formation causes pa-
tients to suffer from severe symptoms, such as dysphagia, vo-
miting, and weight loss. The occurrence of post-ESD stricture
has been associated with mucosal defects to more than three-
quarters of the total circumferential area [4–6], and its inci-
dence has been reported to be greater than 70% [5, 7–9].
Inadequate steroid injection after esophageal ESD might cause
mural necrosis
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ABSTRACT
Background and study aims Locoregional triamcinolone
acetonide (TAC) injection is increasingly used for preven-
tion of stricture after extensive endoscopic submucosal dis-
section (ESD) for superficial esophageal neoplasia. How-
ever, the safety of intramural TAC injection has not been
elucidated. The aim of this study was to assess the clinical
courses and histopathological changes after TAC injection
into the muscle layer in a porcine model.
Methods Three pigs were subjected to ESD under general
anesthesia. Two artificial 30-mm lesions were created at the
oral and anal ends of the esophagus in each pig. TAC was
injected into the muscle layer of the artificial oral ulcers
(TAC group) and saline was injected into the muscle layer
of the artificial anal ulcers (control group). Endoscopic,
macroscopic, and histopathological evaluations were per-
formed.
Results The artificial ulcers remained open at sacrifice on
day 28 post-ESD in the three ulcers injected with TAC.
Esophageal wall perforation and abscess spreading to the
mediastinum were observed in two of the three ulcers in
the TAC group. The abscesses involved the lungs, bronchi,
and aortic adventitia. Severe inflammatory cell infiltration
in the muscularis propria layer and significant muscularis
propria degradation were observed in all three ulcers in
the TAC group.
Conclusions This study suggests that TAC may cause deep
mural damage when it is injected into the muscularis pro-
pria. Care should be taken not to inject TAC into the muscle
layer when it is used to prevent post-ESD stricture forma-
tion.
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Endoscopic balloon dilatation (EBD) is commonly used to treat
strictures; however, EBD sometimes causes complications, such
as perforation, and repeated EBD procedures worsen the pa-
tient’s quality of life [10].
Triamcinolone acetonide (TAC) is a type of corticosteroid
that is used for locoregional injection as a slurry. Some studies
have revealed the significant superiority of locoregional TAC in-
jection to historical control in preventing post-ESD esophageal
stricture formation [8, 11, 12]. Based on these results, TAC is
now widely used in clinical practice. However, corticosteroids
are known to cause tissue vulnerability, and the sustained anti-
inflammatory effects of TAC could sometimes be harmful.
We hypothesized that TAC may be particularly harmful when
it is injected into the muscularis propria; in fact, TAC could
cause vulnerability by inhibiting the deposition and enhancing
the breakdown of collagen to reduce scar-tissue formation [13].
Therefore, the purpose of the present study was to assess the
clinical and histopathological changes after TAC injection into
the muscle layer in a porcine model.
Materials and methods
Study design
This was an experimental animal study using live pigs. Before
TAC injection into the muscularis propria (MP) model, we per-
formed TAC injection into the submucosal layer of three pigs
as a pilot study. Subsequently, a further three female pigs
weighing approximately 15 to 20kg were used for the main
experiment. After 24 hours of fasting, the pigs were subjec-
ted to ESD under general anesthesia induced by the intramus-
cular administration of midazolam (0.2mg/kg), medetomi-
dine (0.1mg/kg), and atropine sulfate (0.02mg/kg), and main-
tained by isoflurane inhalation. After ESD, the pigs received
either TAC (TAC group) or saline injection (control group) into
the muscle layer of the post-ESD artificial ulcers. Oral intake
was started immediately after the procedure. In addition, the
postoperative clinical course (weight and food intake) was
monitored. Esophagoscopy was performed 7, 14, and 28 days
after ESD. The pigs were sacrificed 28 days after the procedure
using an intravenous injection of potassium chloride. The
esophageal tissues were subjected to pathological analyses.
The protocol was reviewed and approved in advance by the
Ethics Review Board of our animal experimental laboratory
(No. 14074).
Creation of the ESD model
Two artificial 30-mm lesions were created 32 and 38 cm from
the incisor of the esophagus in each pig (six lesions in total).
ESD was performed as previously reported [14]. A single chan-
nel endoscope equipped with a waterjet function (GIF-Q260J;
Olympus Medical Systems, Tokyo, Japan), DualKnife J (KD-655
Q; Olympus Medical Systems), and high frequency generator
(ESG-100; Olympus Medical Systems) was used. Glycerol (10%
glycerol and 5% fructose; Chugai Pharmaceutical, Tokyo, Japan)
with a small amount of indigo carmine and 0.1% epinephrine
was injected submucosally around the marking to lift it off the
muscle layer. After the mucosal incisions, the submucosal layer
was dissected to obtain the perfect specimen, and complete en
bloc resection was achieved.
TAC or saline injection into the muscle layer of the
post-ESD ulcer
Immediately after ESD, single injections of endoscopic steroid
or saline were performed in each ESD region. TAC was injected
into the oral ESD site (32 cm incision; TAC group), because we
could not observe the ESD wound on the anal side in case of
severe stricture. In the present study, a TAC slurry (Kenacort;
Bristol-Myers Squibb, New York, USA) was diluted with saline
to make a 5mg/mL solution. After puncturing the appropriate
muscle layer with a 25-gauge, 4-mm needle (TOP Corporation,
Tokyo, Japan), TAC was injected in aliquots of 0.2mL (1mg). A
1-mL syringe was used to inject triamcinolone manually; this
method facilitated injections with constant pressure. The total
amount of triamcinolone injection was 5mL (25mg), which was
distributed approximately equally over 25 punctures. The
endoscopic judgment for muscle injection was made by the
swelling and local white turbidity change by TAC in the muscu-
laris propria layer without these changes in the submucosal lay-
er. For the ulcers on the anal ESD site, an equal volume of nor-
mal saline was injected in the same manner as a control (control
group). All endoscopic procedures, including TAC injection,
were performed by a single expert endoscopist.
Histological assessment
After the pigs were sacrificed, the esophagi were resected with
the surrounding organs and opened longitudinally. The speci-
mens were fixed in 5% buffered formalin for 48 hours and dis-
sected axially at 4-mm intervals. Each piece was embedded in a
paraffin block, cut into 4-μm-thick slices, and examined after
hematoxylin and eosin (HE) and Masson’s trichrome staining.
Results
Submucosal TAC injection model
Typical endoscopic images and histological findings for the TAC
injection site are shown in ▶Fig. 1. There were no perforations
in all three ulcers where TAC was injected into the submucosal
layer. At 28 days after ESD, all artificial ulcers had completely
closed and no stricture was observed. Histological findings re-
vealed mild degeneration of the muscularis propria layer.
Procedure-related outcomes
All procedures were performed successfully in all study animals.
All of the pigs survived the 4 weeks until sacrifice without any
adverse events; additionally, perforation during the ESD proce-
dure, postoperative bleeding, dysphagia, and weight loss were
not observed.
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Endoscopic findings
Typical images obtained for each group are shown in ▶Fig. 2.
The artificial ulcers remained open at sacrifice on day 28 post-
ESD in the three ulcers injected with TAC, whereas the ulcers
were closed completely in two of the three ulcers in the control
group. In ulcers in the TAC group, the ulcers were apparently
deeper than when they were created, and necrotic changes
were observed in the ulcer bed.
Macroscopic findings
Open ulcers were observed in all ulcers in the steroid group as
mentioned above. In two of the three ulcers in the TAC group,
esophageal wall perforation and abscess spread to the media-
stinum were observed. Strong tissue adhesion was observed
between the esophagus and the bronchi, lungs, and aorta
(▶Fig. 3).
Histopathological findings
A summary of the histopathological assessment is shown in
▶Table1. In all three ulcers injected with TAC, the depth of ul-
cers reached the muscularis propria, whereas the depth was
limited to the submucosa in all ulcers in the control group. In
two ulcers in the TAC group, the ulcers penetrated to the
mediastinum, and abscesses were formed. The abscesses in-
volved the lungs, bronchi, and aortic adventitia (▶Fig. 3). In
the control group, the inflammatory cell infiltration was weak
compared with the TAC group apart from one ulcer where the
inflammatory cell infiltration in the submucosal layer and mus-
cularis propria spread beneath the normal mucosa from the
steroid injection site to the saline injection site. The length of
the disrupted muscularis mucosa was longer in the TAC group
than in the control group.Masson’s trichrome staining revealed
significant muscularis propria degradation in the TAC group
(▶Fig. 4). There were no apparent differences in thickness of
the muscularis propria layer between the oral and anal ESD site
on histology.
▶ Fig. 2 Endoscopic images of post-ESD ulcer on day 0, 7, 14, and 28 after ESD. a TAC group (day 0). b TAC group (day 7). c TAC group (day 14).
d TAC group (day 28). e Control group (day 0). f Control group (day 7). g Control group (day 14). h Control group (day 28).
▶ Fig. 1 Endoscopic images and histological findings for TAC injec-
tion site in the pilot study. a Endoscopic image of post-ESD ulcer
(day 0). b Endoscopic image of post-ESD ulcer (day 28). c Typical
appearance of TAC injection site (HE staining). The post-ESD ulcer
had healed completely and mild degeneration of the muscularis
propria layer was found.
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Discussion
As the use of ESD for superficial esophageal cancer has in-
creased, post-ESD stricture has become a major issue. Loco-
regional steroid injection reportedly reduces post-ESD stric-
ture. The occurrence of post-ESD stricture is less than 20% in
patients receiving this treatment and significantly less than
the 66–75% of patients not receiving this treatment [8, 11].
As a result of these data and the benefits of avoiding systemic
steroid administration, locoregional steroid injection is becom-
ing widely used in clinical practice.
On the other hand, tissue TAC concentration seems to be
higher in locoregional injection than in systemic administration
and some adverse events related to locoregional steroid treat-
ment have recently been reported. McAlindon et al. reported
that intra-articular TAC injection in patients with osteoarthritis
▶ Fig. 3 Macroscopic findings for resected specimens and representative sections of TAC injection. a Formalin fixed specimen from pig 1.
b Formalin fixed section with TAC injection in pig 1. c Formalin fixed specimen from pig 2. d Formalin fixed section with TAC injection in pig 2.
e Formalin fixed specimen from pig 3. f Formalin fixed section with TAC injection in pig 3. E represents esophagus, N represents necrotic tissue,
G represents granulation tissue, L represents lung, B represents bronchus, and A represents aorta.
▶ Table 1 Pathological findings for resected esophagus.
Case Treatment Depth of ulcer Penetration Abscess formation Pus on ulcer Disrupted length of MM
1 TAC MP N N Y 11mm
2 TAC Ad Y Y Y 15mm
3 TAC Ad Y Y Y 19mm
4 Control SM N N N 0.7mm
5 Control SM N N N 4mm
6 Control SM N N Y 17mm
MP, muscularis propria; MM, muscularis mucosae; TAC, triamcinolone acetonide; Ad, adventitia; SM, submucosa.
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significantly reduced the knee cartilage volume [15]. Moreover,
there is a case report of delayed perforation after intralesional
TAC injection for esophageal stricture following endoscopic
submucosal dissection [16]. There have been few studies on
the adverse effects of the strong and long-acting anti-inflam-
matory activity of locoregional TAC injection.
Surprisingly, two of the three ulcers in which TAC was injec-
ted developed full-thickness necrosis of the esophagus,
whereas no perforation was observed in the control group and
in ulcers where TAC was injected into the submucosal layer in
the pilot study. The depth of all three ulcers in the TAC group
reached the muscularis propria layer, whereas the ulcers in the
control group remained within the submucosa. Moreover, all
three of the ulcers injected with TAC had not healed at all on
day 28, whereas two of the three ulcers in the control group
had completely closed. These findings indicate that TAC not
only disturbs ulcer healing but also causes mural injury and
necrosis when it is injected into the muscular layer. In clinical
practice, we tried to inject TAC into the submucosal layer, not
into the muscular layer. However, this objective is sometimes
difficult because there is only a small amount of the submuco-
sal layer left after ESD.
Another concern of TAC injection is that the muscularis pro-
pria would be degraded. Tsujii and colleagues reported that the
risk of perforation with endoscopic balloon dilation increased
after TAC injection [17]. The effectiveness of locoregional TAC
injection might not only be because it prevents fibrosis, but
also because it degrades the muscle layer, which leads to in-
complete contraction. In the present study, we found signifi-
cant muscularis propria degradation, as shown by Masson’s tri-
▶ Fig. 4 Histological findings for resected specimens from a TAC injected ulcer and control ulcer. a Specimen of ulcer edge of ulcer injected
with TAC (HE staining). b Specimen of ulcer edge of control ulcer (HE staining). c Specimen of ulcer edge of ulcer injected with TAC (Masson’s
trichrome staining). d Specimen of ulcer edge of control ulcer(Masson’s trichrome staining).
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chrome staining. Therefore, in the case of stricture after TAC in-
jection, the risk of perforation is increased due to tissue vulner-
ability.
The detailed mechanism of why TAC injection into the mus-
cular layer causes mural necrosis is unknown; however, it might
be explained by the catabolic action of glucocorticoids. It is
known that glucocorticoids induce myopathy [18]. Glucocorti-
coids cause skeletal muscle atrophy by promoting protein cata-
bolism and inhibiting protein anabolism. They exert their
effects by binding to the nuclear glucocorticoid receptor (GR).
GR inhibits the activity of mammalian target of rapamycin com-
plex 1 (mTORC1), which is a known promoter of protein anabo-
lism [19]. Moreover, GR enhances the expression of FoxO, a
transcription factor that induces the atrophy-related ubiquitin
ligase atrogin-1 and causes skeletal muscle atrophy [20].
As shown above, locoregional TAC injection might cause
mural necrosis, despite its clinical effectiveness in preventing
post-ESD stricture formation. Recently, novel treatment op-
tions have been proposed for preventing post-ESD stricture;
these treatments include fabricated autologous epidermal cell
sheets [21, 22], absorbefacient polyglycolic acid sheets [23,
24], and siRNAs with anti-fibrotic functions [25]. These novel
treatments are expected to replace TAC if they are effective
and less toxic.
This study has several limitations. Steroid injection into the
muscularis propria was attempted; however, the steroid may
have been accidentally injected into the remnant submucosa.
In this study, only six lesions in three pigs were assessed. TAC
was injected only in the oral ESD site and the difference in loca-
tion might influence the outcomes, though there was no differ-
ence in histological features (e. g. thickness of the wall)
between oral and anal esophagus. Mucosal defects were rela-
tively small and the amount of TAC and puncture time might
have been more than clinical practice even though the differ-
ence was not significant. There may be a species difference
between humans and pigs. Due to these limitations, further
studies are needed.
In conclusion, this study suggests that TAC may cause deep
mural damage when it is injected into the muscularis propria.
We should be careful not to inject TAC into the muscle layer
when it is used to prevent post-ESD stricture formation.
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